ibd and glp 1 More encouraging news about GLP-1 medications. New research presented at ASCO found that patients with inflammatory bowel disease (IBD) who used GLP- receptor agonists had a 51% lower odds of developing colorectal GLPs as novel therapeutic options

Oral rehydration solutions are liquids that contain glucose and electrolytes

With GLP-1 medications like semaglutide and tirzepatide making headlines, many Americans are still unclear on how these treatments work, what the FDA allows, and where to find safe information

Our Insulated Cold Packaging and Gel Packs for Safe Pharmaceutical Shipping Has the GLP-1 boom left you scrambling for the right cold chain process

While delays are common in e-commerce, they can still lead to disappointment when buyers are eager to begin a supplement regimen

In the periphery, GLP-1 agonists enhance glucose-dependent insulin secretion from pancreatic beta cells, suppress inappropriate glucagon release, and slow gastric emptying